These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22844688)

  • 21. Definition of "positional isomer" as it pertains to the control of schedule I controlled substances. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2007 Dec; 72(231):67850-2. PubMed ID: 18064769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schedules of controlled substances: rescheduling of the Food and Drug Administration approved product containing synthetic dronabinol [(-) - [DELTA] less than 9 greater than - (trans)-tetrahydrocannabinol] in sesame oil and encapsulated in soft gelatin capsules from schedule II to schedule III. Department of Justice (DOJ), Drug Enforcement Administration (DEA). Final rule.
    Fed Regist; 1999 Jul; 64(127):35928-30. PubMed ID: 10558581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Schedules of controlled substances: temporary placement of three synthetic cannabinoids into Schedule I. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2013 May; 78(95):28735-9. PubMed ID: 23678676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Anabolic Steroid Control Act of 2004: a study in the political economy of drug policy.
    Denham BE
    J Health Soc Policy; 2006; 22(2):51-78. PubMed ID: 17255072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Schedule of controlled substances: placement of tramadol into schedule IV. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2014 Jul; 79(127):37623-30. PubMed ID: 25016619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of immediate precursor used in the illicit manufacture of fentanyl as a schedule II controlled substance. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2010 Jun; 75(124):37295-9. PubMed ID: 20608285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of red phosphorus, white phosphorus and hypophosphorous acid (and its salts) as list I chemicals; exclusions and waivers. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2003 Jun; 68(121):37411-4. PubMed ID: 12836650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Schedules of controlled substances: placement of suvorexant into Schedule IV. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2014 Aug; 79(167):51243-7. PubMed ID: 25167596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Schedules of Controlled Substances: Placement of AH-7921 Into Schedule I. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 Apr; 81(72):22023-5. PubMed ID: 27101639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Issuance of multiple prescriptions for schedule II controlled substances. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2007 Nov; 72(222):64921-30. PubMed ID: 18038486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Schedules of controlled substances: rescheduling of hydrocodone combination products from schedule III to schedule II. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2014 Aug; 79(163):49661-82. PubMed ID: 25167591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schedules of controlled substances: extension of temporary placement of methylone into schedule I of the Controlled Substances Act. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2012 Oct; 77(202):64032-3. PubMed ID: 23077760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Schedules of controlled substances: temporary placement of four synthetic cannabinoids into Schedule I. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2014 Feb; 79(27):7577-82. PubMed ID: 24605391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exempt chemical mixtures containing gamma-butyrolactone. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2010 Jun; 75(124):37301-7. PubMed ID: 20608286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Authority for practitioners to dispense or prescribe approved narcotic controlled substances for maintenance or detoxification treatment. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2005 Jun; 70(120):36338-44. PubMed ID: 15973789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schedules of Controlled Substances: Removal of [123I]Ioflupane From Schedule II of the Controlled Substances Act. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2015 Sep; 80(176):54715-8. PubMed ID: 26364325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Schedules of Controlled Substances: Placement of Acetyl Fentanyl Into Schedule I. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2017 Jun; 82(108):26349-51. PubMed ID: 28591974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elimination of exemptions for chemical mixtures containing the list I chemicals ephedrine and/or pseudoephedrine. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2008 Jul; 73(133):39611-4. PubMed ID: 18850676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of a chemical precursor used in the illicit manufacture of fentanyl as a List I chemical. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2008 Jul; 73(144):43355-7. PubMed ID: 18949877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substances temporarily controlled under schedule I of the Controlled Substances Act. Final rule; technical amendment.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2015 Mar; 80(54):14842-4. PubMed ID: 25898429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.